Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (8 quarters reported)
$619M in Q4 2020 → $186M now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Progyny, Inc. | 93.0% | Unchanged | 5,074,615 | $173M |
| Pulmonx Corporation | 5.5% | Unchanged | 994,971 | $10.3M |
| Movella Holdings Inc. | 1.5% | Unchanged | 5,189,011 | $2.78M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 7 quarters.
quarter ended September 30, 2023 · filed November 08, 2023
No position changes this quarter.
quarter ended June 30, 2023 · filed August 08, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Progyny, Inc. | Trimmed | −1,398,900 | −$55M | 89.2% |
quarter ended March 31, 2023 · filed May 12, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Movella Holdings Inc. | New | +5,189,011 | +$7.06M | 3.1% |
quarter ended December 31, 2022 · filed February 07, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Transmedics Group, Inc. | Exited | −923,221 | −$30.5M | — |
| Progyny, Inc. | Trimmed | −932,600 | −$29.1M | 96.0% |
| E Epizyme, Inc. | Exited | −3,838,166 | −$19.7M | — |
| Rapid Micro Biosystems, Inc. | Exited | −32,400 | −$598K | — |
quarter ended September 30, 2021 · filed October 25, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Rapid Micro Biosystems, Inc. | New | +32,400 | +$598K | 0.1% |
quarter ended June 30, 2021 · filed July 28, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Progyny, Inc. | Trimmed | −889,781 | −$52.5M | 80.4% |
quarter ended March 31, 2021 · filed May 13, 2021
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Progyny, Inc. | Trimmed | −2,797,800 | −$125M | 75.9% |
| Pulmonx Corporation | Trimmed | −426,415 | −$19.5M | 9.4% |
| Transmedics Group, Inc. | Trimmed | −9,000 | −$373K | 7.9% |
Loading...
